Literature DB >> 15546211

PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.

Aaron M Mohs1, Xinghe Wang, K Craig Goodrich, Yuda Zong, Dennis L Parker, Zheng-Rong Lu.   

Abstract

Biodegradable PEGylated Gd-DTPA l-cystine copolymers, PEG-g-poly(GdDTPA-co-l-cystine), were prepared and tested as a blood pool contrast agent in mice. The biodegradable macromolecular agent was designed to be broken down into smaller Gd complexes by endogenous thiols via the disulfide-thiol exchange reaction to facilitate the clearance of Gd complexes after the contrast-enhanced MRI examination. Gd-DTPA l-cystine copolymers were synthesized by condensation polymerization of l-cystine and DTPA-dianhydride in water followed by chelating with Gd(OAc)(3). MPEG-NH(2) (MW = 2000) was then conjugated to the polymeric backbone in different ratios. The macromolecular contrast agent was readily degraded with the incubation of l-cysteine. It also demonstrated superior contrast enhancement in the heart and blood vessels as compared to a low molecular weight control agent, Gd-(DTPA-BMA). At 1 h postcontrast, the PEGylated macromolecular agent still showed prominent enhancement, while little contrast enhancement was detectable in the blood pool by the control agent. PEG-g-poly(GdDTPA-co-l-cystine) shows promise as an MR blood pool imaging agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546211     DOI: 10.1021/bc049828r

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  17 in total

1.  Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.

Authors:  Todd L Kaneshiro; Tianyi Ke; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2006-06-01       Impact factor: 4.200

2.  Metal-containing and related polymers for biomedical applications.

Authors:  Yi Yan; Jiuyang Zhang; Lixia Ren; Chuanbing Tang
Journal:  Chem Soc Rev       Date:  2016-02-24       Impact factor: 54.564

Review 3.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.

Authors:  Ching-Hui Huang; Andrew Tsourkas
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 5.  Macromolecular and dendrimer-based magnetic resonance contrast agents.

Authors:  Ambika Bumb; Martin W Brechbiel; Peter Choyke
Journal:  Acta Radiol       Date:  2010-09       Impact factor: 1.990

6.  Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.

Authors:  Lindsay S Karfeld-Sulzer; Emily A Waters; Nicolynn E Davis; Thomas J Meade; Annelise E Barron
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

7.  Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.

Authors:  Yi Feng; Lyska Emerson; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

8.  Water-soluble Semiconducting Nanoparticles for Imaging.

Authors:  Chinessa T Adkins; Julia N Dobish; Scott Brown; Eva Harth
Journal:  ACS Macro Lett       Date:  2013-08-20       Impact factor: 6.903

9.  Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agent.

Authors:  Lalit N Goswami; Lixin Ma; Shatadru Chakravarty; Quanyu Cai; Satish S Jalisatgi; M Frederick Hawthorne
Journal:  Inorg Chem       Date:  2012-11-05       Impact factor: 5.165

10.  Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?

Authors:  Joshua Bryson; Jeffrey W Reineke; Theresa M Reineke
Journal:  Macromolecules       Date:  2012-11-13       Impact factor: 5.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.